Pu Ning, Li Jianang, Xu Yaolin, Lee Wanling, Fang Yuan, Han Xu, Zhao Guochao, Zhang Lei, Nuerxiati Abulimiti, Yin Hanlin, Wu Wenchuan, Lou Wenhui
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Department of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Cancer Manag Res. 2018 Feb 5;10:227-238. doi: 10.2147/CMAR.S157940. eCollection 2018.
The prognosis of pancreatic carcinoma (PC) remains poor and the American Joint Committee on Cancer (AJCC) 8th staging system for survival prediction in PC patients after curative resection is still limited. Thus, the aim of this study is to refine a valuable prognostic model and novel staging system for PC with curative resection.
The data of 3,458 patients used in this study were retrieved from the Surveillance, Epidemiology, and End Results database registry of National Cancer Institute. The prognostic value of lymph node ratio (LNR) was analyzed in the primary cohort and prognostic nomogram based on the LNR was established to create a novel staging system. Then, analyses were conducted to evaluate the application of the formulated nomogram staging system and the AJCC 8th staging system. The predictive performance of model was further validated in the internal validation cohort.
Significant positive correlations were found between LNR and all factors except for surgical procedures. The results of univariate and multivariate analyses showed that LNR was identified as an independent prognostic indicator for overall survival (OS) in both primary and validation cohorts (all < 0.001). A prognostic nomogram based on the LNR was formulated to obtain superior discriminatory abilities. Compared with the AJCC 8th staging system, the formulated nomogram staging system showed higher hazard ratios of stage II, III, and IV disease (reference to stage I disease) that were 1.637, 2.300, and 3.521, respectively, by univariate analyses in the primary cohort and the distinction between stage I, II, and III disease at the beginning or end of the survival curves was more apparent. All these results were further verified in the validation cohort.
LNR can be considered as a useful independent prognostic indicator for PC patients after curative resection regardless of the surgical procedures. Compared with the AJCC 8th staging system, the formulated nomogram showed superior predictive accuracy for OS and its novel staging system revealed better risk stratification.
胰腺癌(PC)的预后仍然很差,美国癌症联合委员会(AJCC)第八版用于预测根治性切除术后PC患者生存情况的分期系统仍存在局限性。因此,本研究的目的是优化一种用于根治性切除PC的有价值的预后模型和新分期系统。
本研究使用的3458例患者的数据取自美国国立癌症研究所的监测、流行病学和最终结果数据库登记处。在主要队列中分析淋巴结比率(LNR)的预后价值,并建立基于LNR的预后列线图以创建新的分期系统。然后,进行分析以评估制定的列线图分期系统和AJCC第八版分期系统的应用。该模型的预测性能在内部验证队列中进一步得到验证。
除手术方式外,LNR与所有因素之间均存在显著正相关。单因素和多因素分析结果显示,在主要队列和验证队列中,LNR均被确定为总生存期(OS)的独立预后指标(均P<0.001)。制定了基于LNR的预后列线图以获得更好的区分能力。与AJCC第八版分期系统相比,在主要队列的单因素分析中,制定的列线图分期系统显示II期、III期和IV期疾病(以I期疾病为参照)的风险比更高,分别为1.637、2.300和3.521,并且生存曲线起点或终点处I期、II期和III期疾病之间的区分更明显。所有这些结果在验证队列中进一步得到证实。
无论手术方式如何,LNR均可被视为根治性切除术后PC患者有用的独立预后指标。与AJCC第八版分期系统相比,制定的列线图对OS显示出更高的预测准确性,其新分期系统显示出更好的风险分层。